DOW JONES27,961.62-1030.79 -3.56%
S&P 5003,225.93-111.82 -3.35%
NASDAQ9,221.28-355.31 -3.71%

Nomura Maintains Buy on Alexion Pharmaceuticals, Lowers Price Target to $133

Nomura maintains Alexion Pharmaceuticals (NASDAQ:ALXN) with a Buy and lowers the price target from $165 to $133.

Benzinga · 02/03/2020 14:24

Nomura maintains Alexion Pharmaceuticals (NASDAQ:ALXN) with a Buy and lowers the price target from $165 to $133.